全文获取类型
收费全文 | 749篇 |
免费 | 83篇 |
国内免费 | 57篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 6篇 |
妇产科学 | 5篇 |
基础医学 | 95篇 |
口腔科学 | 3篇 |
临床医学 | 67篇 |
内科学 | 144篇 |
皮肤病学 | 9篇 |
神经病学 | 71篇 |
特种医学 | 5篇 |
外科学 | 36篇 |
综合类 | 114篇 |
预防医学 | 140篇 |
眼科学 | 3篇 |
药学 | 76篇 |
中国医学 | 76篇 |
肿瘤学 | 35篇 |
出版年
2023年 | 21篇 |
2022年 | 44篇 |
2021年 | 47篇 |
2020年 | 54篇 |
2019年 | 28篇 |
2018年 | 27篇 |
2017年 | 28篇 |
2016年 | 38篇 |
2015年 | 36篇 |
2014年 | 78篇 |
2013年 | 76篇 |
2012年 | 63篇 |
2011年 | 67篇 |
2010年 | 43篇 |
2009年 | 39篇 |
2008年 | 32篇 |
2007年 | 34篇 |
2006年 | 17篇 |
2005年 | 11篇 |
2004年 | 12篇 |
2003年 | 9篇 |
2002年 | 4篇 |
2001年 | 12篇 |
2000年 | 6篇 |
1999年 | 6篇 |
1998年 | 4篇 |
1997年 | 4篇 |
1996年 | 2篇 |
1995年 | 5篇 |
1994年 | 5篇 |
1993年 | 2篇 |
1992年 | 2篇 |
1991年 | 1篇 |
1990年 | 3篇 |
1989年 | 2篇 |
1987年 | 3篇 |
1984年 | 1篇 |
1983年 | 2篇 |
1982年 | 5篇 |
1978年 | 3篇 |
1976年 | 1篇 |
1975年 | 3篇 |
1974年 | 1篇 |
1973年 | 2篇 |
1972年 | 2篇 |
1971年 | 1篇 |
1970年 | 1篇 |
1969年 | 2篇 |
排序方式: 共有889条查询结果,搜索用时 15 毫秒
1.
《Saudi Pharmaceutical Journal》2022,30(11):1572-1588
Non-alcoholic fatty liver disease (NAFLD) is one of the most common complications of a metabolic syndrome caused by excessive accumulation of fat in the liver. Orthosiphon stamineus also known as Orthosiphon aristatus is a medicinal plant with possible potential beneficial effects on various metabolic disorders. This study aims to investigate the in vitro inhibitory effects of O. stamineus on hepatic fat accumulation and to further use the computational systems pharmacology approach to identify the pharmacokinetic properties of the bioactive compounds of O. stamineus and to predict their molecular mechanisms against NAFLD. Methods: The effects of an ethanolic extract of O. stamineus leaves on cytotoxicity, fat accumulation and antioxidant activity were assessed using HepG2 cells. The bioactive compounds of O. stamineus were identified using LC/MS and two bioinformatics databases, namely the Traditional Chinese Medicine Integrated Database (TCMID) and the Bioinformatics Analysis Tool for the Molecular Mechanism of Traditional Chinese Medicine (BATMAN-TCM). Pathway enrichment analysis was performed on the predicted targets of the bioactive compounds to provide a systematic overview of the molecular mechanism of action, while molecular docking was used to validate the predicted targets. Results: A total of 27 bioactive compounds corresponding to 50 potential NAFLD-related targets were identified. O. stamineus exerts its anti-NAFLD effects by modulating a variety of cellular processes, including oxidative stress, mitochondrial β-oxidation, inflammatory signalling pathways, insulin signalling, and fatty acid homeostasis pathways. O. stamineus is significantly targeting many oxidative stress regulators, including JNK, mammalian target of rapamycin (mTOR), NFKB1, PPAR, and AKT1. Molecular docking analysis confirmed the expected high affinity for the potential targets, while the in vitro assay indicates the ability of O. stamineus to inhibit hepatic fat accumulation. Conclusion: Using the computational systems pharmacology approach, the potentially beneficial effect of O. stamineus in NAFLD was indicated through the combination of multiple compounds, multiple targets, and multicellular components. 相似文献
2.
目的 探讨路径式营养管理在食管癌围术期患者中的应用效果。方法 选取2018年1月至2018年7月在四川省肿瘤医院胸外科接受食管癌根治手术治疗的患者156例,随机分为干预组(n=78)和对照组(n=78),干预组采用路径式营养管理,对照组采用常规营养管理,比较两组患者在术后7d血红蛋白、前白蛋白、体质指数(BMI)、预后营养指数(PNI)等营养指标、术后并发症发生率及术后住院时间。结果 干预组患者术后7d血红蛋白(126.09±16.69)g/L、前白蛋白(208.74±38.51)mg/L、BMI(22.28±2.05)kg/m2、PNI(46.62±4.03)优于对照组,差异有统计学意义(P<0.05);干预组患者胸腔积液发生率低于对照组,差异有统计学意义(t=4.02,P=0.04);干预组患者住院时间短于对照组,差异有统计学意义(t=6.53,P=0.03)。结论 路径式营养管理能有效改善食管癌围术期患者营养状况、降低并发症发生率、缩短术后住院时间。 相似文献
3.
《Neuro-Chirurgie》2021,67(4):336-345
ObjectOptic pathway tumors (OPT) represent a challenge for pediatric neurosurgeons. Role of surgery is debated due to the high risk of iatrogenic damage, and in lasts decades it lost its importance in favor of chemotherapy. However, in some cases surgery is necessary to make biomolecular and histological diagnosis, to manage intracranial hypertension (IH) and to cooperate with medical therapies in controlling tumor relapse. With the aim to standardize selection of surgical OPT cases, we propose a simple, practical and reproducible classification.MethodsWe retrospectively analyzed data of 38 patients with OPT treated at our institution (1990–2018). After careful analysis of MRI images, we describe a new classification system. Group 1: lesion limited to one or both optic nerve(s). Group 2: chiasmatic lesions extending minimally to hypothalamus. Group 3: hypothalamo-chiasmatic exophitic lesions invading the third ventricle; they can be further divided on the base of concomitant hydrocephalus. Group 4: hypothalamo-chiasmatic lesions extending widely in lateral direction, toward the temporal or the frontal lobes. Patients’ data and adopted treatment are reported and analyzed, also depending on this classification.ResultsTwenty children were operated on for treatment of OPT during the study period. Permanent clinical impairment was noted in 5 (25%) of operated patients, while visual improvement was noted in 1 patient. OS rate was 100% at 5 years, with a median follow up of 9 years (ranging from 2 to 23). Prevalence of intracranial hypertension and proportion of first-line surgical treatment decision were significantly higher in groups 3-4 compared to groups 1-2 (P < 0.001 for both tests).ConclusionSurgery can offer a valuable therapeutic complement for OPT without major risk of iatrogenic damage. Surgery is indispensable in cases presenting with IH, as in groups 3 and 4 lesions. Eligibility of patients to surgery can be based on this new classification system. 相似文献
4.
5.
6.
7.
8.
《Journal of vascular and interventional radiology : JVIR》2020,31(3):482-491.e4
PurposeTo determine the safety and feasibility of percutaneous high-frequency irreversible electroporation (HFIRE) for primary liver cancer and evaluate the HFIRE-induced local immune response.Materials and MethodsHFIRE therapy was delivered percutaneously in 3 canine patients with resectable hepatocellular carcinoma (HCC) in the absence of intraoperative paralytic agents or cardiac synchronization. Pre- and post-HFIRE biopsy samples were processed with histopathology and immunohistochemistry for CD3, CD4, CD8, and CD79a. Blood was collected on days 0, 2, and 4 for complete blood count and chemistry. Numeric models were developed to determine the treatment-specific lethal thresholds for malignant canine liver tissue and healthy porcine liver tissue.ResultsHFIRE resulted in predictable ablation volumes as assessed by posttreatment CT. No detectable cardiac interference and minimal muscle contraction occurred during HFIRE. No clinically significant adverse events occurred secondary to HFIRE. Microscopically, a well-defined ablation zone surrounded by a reactive zone was evident in the majority of samples. This zone was composed primarily of maturing collagen interspersed with CD3+/CD4−/CD8− lymphocytes in a proinflammatory microenvironment. The average ablation volumes for the canine HCC patients and the healthy porcine tissue were 3.89 cm3 ± 0.74 and 1.56 cm3 ± 0.16, respectively (P = .03), and the respective average lethal thresholds were 710 V/cm ± 28.2 and 957 V/cm ± 24.4 V/cm (P = .0004).ConclusionsHFIRE can safely and effectively be delivered percutaneously, results in a predictable ablation volume, and is associated with lymphocytic tumor infiltration. This is the first step toward the use of HFIRE for treatment of unresectable liver tumors. 相似文献
9.
《Drug metabolism and pharmacokinetics》2019,34(5):340-349
The present study aims is to investigate the metabolic mechanism of Xue-Fu-Zhu-Yu decoction (XFZYD) in the treatment of blood-stasis syndrome in Coronary Heart Disease (CHD). To that end, 30 CHD patients with Blood-Stasis Syndrome (BSS) and 20 healthy subjects were enrolled. LC-Q-TOF/MS analysis determined that in comparison between CHD with BSS patients (Group A) and healthy subjects (Group C), 59 significantly differential metabolites in the positive mode and 18 significantly differential metabolites in the negative mode. The metabolite constituents in the plasma of 30 CHD with BSS patients before (group A) and after 30 days of treatment (Group B), and 20 healthy subjects (Group C) were analyzed using LC-Q-TOF/MS and GC-MS. Based on multivariate statistical analysis (PCA, PLS-DA and OPLS-DA), we determined 69 differential metabolites. The levels of hemorheology indexes were significantly down-regulated after treatment. Metabolic pathway attribution analysis showed that lipid metabolism, amino acid metabolism and bile acid metabolism pathways are involved. Our study identifies the metabolic networks of CHD and demonstrates the efficacy of this metabolomics approach to systematically study the therapeutic effect of XFZYC on CHD. 相似文献
10.
目的分析临床护理路径建立对急性非静脉曲张性上消化道出血(ANVUGIB)患者再出血及预后的影响。方法选择医院诊治的ANVUGIB患者63例,分为对照组(n=33)和干预组(n=30)。对照组予以常规护理干预,干预组采取临床护理路径干预,比较两组护理效果。结果干预组患者护理总满意率96.67%,高于对照组(66.67%,P<0.05);干预后,干预组患者血红蛋白水平高于对照组,血尿素氮水平低于对照组(P<0.05);干预后,干预组患者BRS积分、患者再出血率低于对照组,依从率(90.00%)高于对照组(63.64%,P<0.05)。结论临床护理路径能明显提升ANVUGIB患者预后,减少再出血风险,改善营养与代谢指标。 相似文献